BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1086 related articles for article (PubMed ID: 16715031)

  • 41. Differential diagnostic value of procalcitonin in surgical and medical patients with septic shock.
    Clec'h C; Fosse JP; Karoubi P; Vincent F; Chouahi I; Hamza L; Cupa M; Cohen Y
    Crit Care Med; 2006 Jan; 34(1):102-7. PubMed ID: 16374163
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction.
    Castelli GP; Pognani C; Meisner M; Stuani A; Bellomi D; Sgarbi L
    Crit Care; 2004 Aug; 8(4):R234-42. PubMed ID: 15312223
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Procalcitonin versus C-reactive protein for guiding antibiotic therapy in sepsis: a randomized trial.
    Oliveira CF; Botoni FA; Oliveira CR; Silva CB; Pereira HA; Serufo JC; Nobre V
    Crit Care Med; 2013 Oct; 41(10):2336-43. PubMed ID: 23921272
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of the delta neutrophil index with procalcitonin and C-reactive protein in sepsis.
    Kim H; Kim Y; Lee HK; Kim KH; Yeo CD
    Clin Lab; 2014; 60(12):2015-21. PubMed ID: 25651736
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Procalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock--a systematic review and meta-analysis.
    Prkno A; Wacker C; Brunkhorst FM; Schlattmann P
    Crit Care; 2013 Dec; 17(6):R291. PubMed ID: 24330744
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit.
    BalcI C; Sungurtekin H; Gürses E; Sungurtekin U; Kaptanoglu B
    Crit Care; 2003 Feb; 7(1):85-90. PubMed ID: 12617745
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of Fcγ receptor expression on neutrophils with procalcitonin for the diagnosis of sepsis in critically ill patients.
    Hsu KH; Chan MC; Wang JM; Lin LY; Wu CL
    Respirology; 2011 Jan; 16(1):152-60. PubMed ID: 20946336
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Prognostic value of procalcitonin, C-reactive protein and leukocytes in septic shock].
    Suberviola B; Castellanos-Ortega A; González-Castro A; García-Astudillo LA; Fernández-Miret B
    Med Intensiva; 2012 Apr; 36(3):177-84. PubMed ID: 22055776
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Systematic review and meta-analysis of the diagnostic accuracy of procalcitonin, C-reactive protein and white blood cell count for suspected acute appendicitis.
    Yu CW; Juan LI; Wu MH; Shen CJ; Wu JY; Lee CC
    Br J Surg; 2013 Feb; 100(3):322-9. PubMed ID: 23203918
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Procalcitonin algorithm in critically ill adults with undifferentiated infection or suspected sepsis. A randomized controlled trial.
    Shehabi Y; Sterba M; Garrett PM; Rachakonda KS; Stephens D; Harrigan P; Walker A; Bailey MJ; Johnson B; Millis D; Ding G; Peake S; Wong H; Thomas J; Smith K; Forbes L; Hardie M; Micallef S; Fraser JF; ;
    Am J Respir Crit Care Med; 2014 Nov; 190(10):1102-10. PubMed ID: 25295709
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic value of the biomarkers procalcitonin, interleukin-6 and C-reactive protein in severe sepsis.
    Miguel-Bayarri V; Casanoves-Laparra EB; Pallás-Beneyto L; Sancho-Chinesta S; Martín-Osorio LF; Tormo-Calandín C; Bautista-Rentero D
    Med Intensiva; 2012 Nov; 36(8):556-62. PubMed ID: 22495097
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Procalcitonin: a marker to clearly differentiate systemic inflammatory response syndrome and sepsis in the critically ill patient?
    Giamarellos-Bourboulis EJ; Mega A; Grecka P; Scarpa N; Koratzanis G; Thomopoulos G; Giamarellou H
    Intensive Care Med; 2002 Sep; 28(9):1351-6. PubMed ID: 12209289
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of serum C-reactive protein, procalcitonin, tumor necrosis factor alpha, and interleukin-10 levels as diagnostic and prognostic parameters in patients with community-acquired sepsis, severe sepsis, and septic shock.
    Heper Y; Akalin EH; Mistik R; Akgöz S; Töre O; Göral G; Oral B; Budak F; Helvaci S
    Eur J Clin Microbiol Infect Dis; 2006 Aug; 25(8):481-91. PubMed ID: 16896829
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Head-to-head comparison of procalcitonin and presepsin for the diagnosis of sepsis in critically ill adult patients: a protocol for a systematic review and meta-analysis.
    Hayashida K; Kondo Y; Hara Y; Aihara M; Yamakawa K
    BMJ Open; 2017 Mar; 7(3):e014305. PubMed ID: 28264831
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical Usefulness of Procalcitonin and C-Reactive Protein as Outcome Predictors in Critically Ill Patients with Severe Sepsis and Septic Shock.
    Ryu JA; Yang JH; Lee D; Park CM; Suh GY; Jeon K; Cho J; Baek SY; Carriere KC; Chung CR
    PLoS One; 2015; 10(9):e0138150. PubMed ID: 26367532
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Should procalcitonin be introduced in the diagnostic criteria for the systemic inflammatory response syndrome and sepsis?
    Giamarellos-Bourboulis EJ; Giannopoulou P; Grecka P; Voros D; Mandragos K; Giamarellou H
    J Crit Care; 2004 Sep; 19(3):152-7. PubMed ID: 15484175
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic evaluation of severe sepsis and septic shock: procalcitonin clearance vs Δ Sequential Organ Failure Assessment.
    de Azevedo JR; Torres OJ; Beraldi RA; Ribas CA; Malafaia O
    J Crit Care; 2015 Feb; 30(1):219.e9-12. PubMed ID: 25241933
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills?
    Sridharan P; Chamberlain RS
    Surg Infect (Larchmt); 2013 Dec; 14(6):489-511. PubMed ID: 24274059
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of procalcitonin, C-reactive protein, interleukin-6, interleukin-8 and tumor necrosis factor-alpha in the diagnosis of neonatal sepsis.
    Kocabaş E; Sarikçioğlu A; Aksaray N; Seydaoğlu G; Seyhun Y; Yaman A
    Turk J Pediatr; 2007; 49(1):7-20. PubMed ID: 17479639
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Procalcitonin, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in community-acquired infections and sepsis: a prospective study.
    Gaïni S; Koldkjaer OG; Pedersen C; Pedersen SS
    Crit Care; 2006; 10(2):R53. PubMed ID: 16569262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 55.